Literature DB >> 1612758

Interaction of Mycoplasma dispar with bovine alveolar macrophages.

R A Almeida1, M J Wannemuehler, R F Rosenbusch.   

Abstract

The capacity to avoid phagocytosis and the activation of bovine alveolar macrophages (BAM) by encapsulated Mycoplasma dispar or purified M. dispar capsule was investigated. Encapsulated and unencapsulated M. dispar were cocultured with BAM in the presence or absence of antisera prepared against unencapsulated M. dispar or purified capsule antiserum. Unopsonized mycoplasmas resisted phagocytosis, while only anti-capsule antibodies enhanced the phagocytosis of encapsulated mycoplasmas. BAM were cultured in the presence of purified M. dispar capsule or either live or heat-killed encapsulated or unencapsulated M. dispar. These BAM were then activated with Escherichia coli endotoxin or left without further activation. The supernatants of these cultures were assayed for tumor necrosis factor, interleukin 1, and glucose consumption as indicators of macrophage activation. Tumor necrosis factor and interleukin 1 were produced by BAM stimulated with unencapsulated M. dispar but not when encapsulated M. dispar or its purified capsule was used. Similarly, glucose consumption was increased in the presence of unencapsulated M. dispar, but not when BAM were cocultured with encapsulated M. dispar or purified capsule. When BAM were treated with purified capsule or encapsulated mycoplasmas, they could not be subsequently activated by endotoxin. These results indicate that encapsulated M. dispar or purified capsule exerts an inhibitory effect on the activity of BAM and prevents the activation of these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612758      PMCID: PMC257254          DOI: 10.1128/iai.60.7.2914-2919.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Lung macrophages: how many kinds are there? What do they do?

Authors:  J D Brain
Journal:  Am Rev Respir Dis       Date:  1988-03

2.  Transmission of Mycoplasma dispar among calves collected and reared for beef production.

Authors:  R Tanskanen
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

3.  Resolution of pulmonary inflammation.

Authors:  P M Henson; G L Larsen; J E Henson; S L Newman; R A Musson; C C Leslie
Journal:  Fed Proc       Date:  1984-10

4.  Capsulelike surface material of Mycoplasma dispar induced by in vitro growth in culture with bovine cells is antigenically related to similar structures expressed in vivo.

Authors:  R A Almeida; R F Rosenbusch
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Interaction of Mycoplasma arthritidis and other mycoplasmas with murine peritoneal macrophages.

Authors:  B C Cole; J R Ward
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

6.  Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa.

Authors:  D P Speert; S D Wright; S C Silverstein; B Mah
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Identification of Mycoplasmatales in pneumonic calf lungs.

Authors:  W U Knudtson; D E Reed; G Daniels
Journal:  Vet Microbiol       Date:  1986-02       Impact factor: 3.293

8.  Induction of class II MHC antigen expression in macrophages by Mycoplasma species.

Authors:  P M Stuart; G H Cassell; J G Woodward
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

9.  Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.

Authors:  G B Pier; J M Saunders; P Ames; M S Edwards; H Auerbach; J Goldfarb; D P Speert; S Hurwitch
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

10.  The interaction in vitro of Mycoplasma pulmonis with mouse peritoneal macrophages and L-cells.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

View more
  10 in total

1.  Identification and serological specificity of a polysaccharide component from Mycoplasma bovis.

Authors:  B W Brooks; C L Lutze-Wallace; P Lu; R H Robertson
Journal:  Vet Res Commun       Date:  2004-04       Impact factor: 2.459

2.  Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytes.

Authors:  D A Kostyal; G H Butler; D H Beezhold
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

3.  Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.

Authors:  C B Faulkner; J W Simecka; M K Davidson; J K Davis; T R Schoeb; J R Lindsey; M P Everson
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 4.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.

Authors:  Brandon M Shaw; James M Daubenspeck; Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-11-28       Impact factor: 2.742

6.  Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.

Authors:  Preston J Hill; Julia M Scordo; Jesús Arcos; Stephen E Kirkby; Mark D Wewers; Daniel J Wozniak; Jordi B Torrelles
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

7.  In vivo role of capsular polysaccharide in Mycoplasma mycoides.

Authors:  Joerg Jores; Elise Schieck; Anne Liljander; Flavio Sacchini; Horst Posthaus; Carole Lartigue; Alain Blanchard; Fabien Labroussaa; Sanjay Vashee
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

Review 8.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

9.  Free exopolysaccharide from Mycoplasma mycoides subsp. mycoides possesses anti-inflammatory properties.

Authors:  Philippe Totté; Carinne Puech; Valérie Rodrigues; Clothilde Bertin; Lucia Manso-Silvan; François Thiaucourt
Journal:  Vet Res       Date:  2015-10-21       Impact factor: 3.683

10.  Ureaplasma diversum Genome Provides New Insights about the Interaction of the Surface Molecules of This Bacterium with the Host.

Authors:  Lucas M Marques; Izadora S Rezende; Maysa S Barbosa; Ana M S Guimarães; Hellen B Martins; Guilherme B Campos; Naíla C do Nascimento; Andrea P Dos Santos; Aline T Amorim; Verena M Santos; Sávio T Farias; Fernanda  C Barrence; Lauro M de Souza; Melissa Buzinhani; Victor E Arana-Chavez; Maria E Zenteno; Gustavo P Amarante-Mendes; Joanne B Messick; Jorge Timenetsky
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.